- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 128,520 | 28.06.24 20:58:02 | -1,300 | -1,00% | 128,510 | 128,520 | 131,990 | 129,820 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 83,975 | 28.06.24 20:57:30 | +1,645 | +2,00% | 83,830 | 84,120 | 82,720 | 82,330 |
